Article
Refining the diagnostic utility of OLFM4 in gastric cancer precursors: a call for rigorous methodologies
8 Aug 2024
Abstract excerpt
This commentary offers a thoughtful discussion of the study by Wei et al. published in the journal on the role of Olfactomedin 4 (OLFM4) in incomplete intestinal metaplasia, a gastric precancerous condition. The original paper introduces OLFM4 as a novel biomarker with potential enhanced diagnostic efficacy compared to established markers. However, several methodological and interpretive considerations are noted....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
